SCHEMBL25005393

SCHEMBL25005393

CC(=O)Nc1c(C)cccc1Nc1nc(Cl)ncc1Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.46
CCNA2 P20248 3/20 0.43
CDK2 P24941 3/20 0.43
CCNK O75909 2/20 0.43
CCND3 P30281 2/20 0.43
CDK9 P50750 2/20 0.43
CDK6 Q00534 2/20 0.43
LRRK2 Q5S007 1/20 0.41
MAPK3 P27361 2/20 0.41
ULK1 O75385 1/20 0.41
EGFR P00533 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.40
ROS1 P08922 1/20 0.39
ALK Q9UM73 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31147673 1.00 LCK (0.46) LCKCCNA2CDK2CCNKCCND3
SCHEMBL1221669 0.88 AURKA (0.43) LCKCDK2EGFRALDH1A1HPGD
SCHEMBL602415 0.87 MAPK3 (0.40) MAPK3ULK1EGFRROS1ALK
SCHEMBL25005392 0.85 MAPK3 (0.41) LCKCCNA2CDK2CCNKCCND3
SCHEMBL29904740 0.83 ROS1 (0.52) MAPK3ULK1EGFRROS1ALK
SCHEMBL25004486 0.83 ROS1 (0.52) MAPK3ULK1EGFRROS1ALK
SCHEMBL634522 0.81 ALK (0.44) CCNA2CDK2CCNKCCND3CDK9
SCHEMBL31147617 0.81 ALK (0.44) CCNA2CDK2CCNKCCND3CDK9
SCHEMBL30366835 0.79 FGFR4 (0.56) MAPK3
SCHEMBL28658752 0.79 CCNA2 (0.50) CCNA2CDK2CCNKCCND3CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382514-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2024-06-12 EP disclosed
WO-2023014022-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 한국화학연구원 2023-02-09 WO disclosed